BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 31703057)

  • 1. Overexpression of Tripartite Motif-Containing 48 (TRIM48) Inhibits Growth of Human Glioblastoma Cells by Suppressing Extracellular Signal Regulated Kinase 1/2 (ERK1/2) Pathway.
    Xue LP; Lu B; Gao BB; Shi YY; Xu JQ; Yang R; Xu B; Ding P
    Med Sci Monit; 2019 Nov; 25():8422-8429. PubMed ID: 31703057
    [TBL] [Abstract][Full Text] [Related]  

  • 2. β-Elemene inhibits proliferation through crosstalk between glia maturation factor β and extracellular signal‑regulated kinase 1/2 and impairs drug resistance to temozolomide in glioblastoma cells.
    Zhu TZ; Li XM; Luo LH; Xu YH; Cao P; Liu Y; Liang GB
    Mol Med Rep; 2014 Aug; 10(2):1122-8. PubMed ID: 24866280
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Both mitogen-activated protein kinase (MAPK)/extracellular-signal-regulated kinases (ERK) 1/2 and phosphatidylinositide-3-OH kinase (PI3K)/Akt pathways regulate activation of E-twenty-six (ETS)-like transcription factor 1 (Elk-1) in U138 glioblastoma cells.
    Mut M; Lule S; Demir O; Kurnaz IA; Vural I
    Int J Biochem Cell Biol; 2012 Feb; 44(2):302-10. PubMed ID: 22085529
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TRIM65 is a potential oncogenic protein via ERK1/2 on Jurkat and Raji cells: A therapeutic target in human lymphoma malignancies.
    Wang J; Liang X; Yu T; Xu YL; Xu LH; Zhang XJ; Ma J; Wang YR; He SL
    Cell Biol Int; 2018 Nov; 42(11):1503-1510. PubMed ID: 30039885
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protease-activated receptor-2 (PAR2) mediates VEGF production through the ERK1/2 pathway in human glioblastoma cell lines.
    Dutra-Oliveira A; Monteiro RQ; Mariano-Oliveira A
    Biochem Biophys Res Commun; 2012 May; 421(2):221-7. PubMed ID: 22497886
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The role of mitogen-activated protein kinase cascades in inhibition of proliferation in human prostate carcinoma cells by raloxifene: an in vitro experiment].
    Zhang YX; Kong CZ
    Zhonghua Yi Xue Za Zhi; 2008 Jan; 88(4):271-5. PubMed ID: 18361842
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sustained activation of extracellular-signal-regulated kinase 1 (ERK1) is required for the continued expression of cyclin D1 in G1 phase.
    Weber JD; Raben DM; Phillips PJ; Baldassare JJ
    Biochem J; 1997 Aug; 326 ( Pt 1)(Pt 1):61-8. PubMed ID: 9337851
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Curcumin enhances the radiosensitivity of U87 cells by inducing DUSP-2 up-regulation.
    Qian Y; Ma J; Guo X; Sun J; Yu Y; Cao B; Zhang L; Ding X; Huang J; Shao JF
    Cell Physiol Biochem; 2015; 35(4):1381-93. PubMed ID: 25792385
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activation of ERK and Mutual Regulation of Stat3 and SP1 Contribute to Inhibition of PDK1 Expression by Atractylenolide-1 in Human Lung Cancer Cells.
    Xiao Q; Zheng F; Wu J; Tang Q; Wang W; Hann SS
    Cell Physiol Biochem; 2017; 43(6):2353-2366. PubMed ID: 29073620
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of ERK1/2 Signaling Pathway is Involved in Melatonin's Antiproliferative Effect on Human MG-63 Osteosarcoma Cells.
    Liu L; Xu Y; Reiter RJ; Pan Y; Chen D; Liu Y; Pu X; Jiang L; Li Z
    Cell Physiol Biochem; 2016; 39(6):2297-2307. PubMed ID: 27832629
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cell-cycle arrest by PD184352 requires inhibition of extracellular signal-regulated kinases (ERK) 1/2 but not ERK5/BMK1.
    Squires MS; Nixon PM; Cook SJ
    Biochem J; 2002 Sep; 366(Pt 2):673-80. PubMed ID: 12069688
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Curcumin reverses benzidine-induced cell proliferation by suppressing ERK1/2 pathway in human bladder cancer T24 cells.
    Sun X; Deng QF; Liang ZF; Zhang ZQ; Zhao L; Geng H; Xie DD; Wang Y; Yu DX; Zhong CY
    Exp Toxicol Pathol; 2016 Apr; 68(4):215-22. PubMed ID: 26776764
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lipoxin A4 inhibits proliferation and inflammatory cytokine/chemokine production of human epidermal keratinocytes associated with the ERK1/2 and NF-κB pathways.
    Hu F; Liu XX; Wang X; Alashkar M; Zhang S; Xu JT; Zhong XL; He MW; Feng AP; Chen HX
    J Dermatol Sci; 2015 Jun; 78(3):181-8. PubMed ID: 25847211
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Cyclin-dependent kinase inhibitor CYC202 (R-roscovitine) inhibits retinoblastoma protein phosphorylation, causes loss of Cyclin D1, and activates the mitogen-activated protein kinase pathway.
    Whittaker SR; Walton MI; Garrett MD; Workman P
    Cancer Res; 2004 Jan; 64(1):262-72. PubMed ID: 14729633
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Requirement of ClC-3 in G0/G1 to S Phase Transition Induced by IGF-1 via ERK1/2-Cyclins Cascade in Multiple Myeloma Cells.
    Du Y; Tu YS; Tang YB; Huang YY; Zhou FM; Tian T; Li XY
    Clin Lab; 2018 Jun; 64(6):929-936. PubMed ID: 29945325
    [TBL] [Abstract][Full Text] [Related]  

  • 16. LRRC4 inhibits human glioblastoma cells proliferation, invasion, and proMMP-2 activation by reducing SDF-1 alpha/CXCR4-mediated ERK1/2 and Akt signaling pathways.
    Wu M; Chen Q; Li D; Li X; Li X; Huang C; Tang Y; Zhou Y; Wang D; Tang K; Cao L; Shen S; Li G
    J Cell Biochem; 2008 Jan; 103(1):245-55. PubMed ID: 17549698
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diazepam inhibits proliferation of human glioblastoma cells through triggering a G0/G1 cell cycle arrest.
    Chen J; Ouyang Y; Cao L; Zhu W; Zhou Y; Zhou Y; Zhang H; Yang X; Mao L; Lin S; Lin J; Hu J; Yan G
    J Neurosurg Anesthesiol; 2013 Jul; 25(3):285-91. PubMed ID: 23519373
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peiminine Inhibits Glioblastoma in Vitro and in Vivo Through Cell Cycle Arrest and Autophagic Flux Blocking.
    Zhao B; Shen C; Zheng Z; Wang X; Zhao W; Chen X; Peng F; Xue L; Shu M; Hou X; Wang K; Zhong C; Sun J; Wan J; Zhao S
    Cell Physiol Biochem; 2018; 51(4):1566-1583. PubMed ID: 30497066
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activation of GPR30 inhibits the growth of prostate cancer cells through sustained activation of Erk1/2, c-jun/c-fos-dependent upregulation of p21, and induction of G(2) cell-cycle arrest.
    Chan QK; Lam HM; Ng CF; Lee AY; Chan ES; Ng HK; Ho SM; Lau KM
    Cell Death Differ; 2010 Sep; 17(9):1511-23. PubMed ID: 20203690
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Esculetin inhibits cell proliferation through the Ras/ERK1/2 pathway in human colon cancer cells.
    Park SS; Park SK; Lim JH; Choi YH; Kim WJ; Moon SK
    Oncol Rep; 2011 Jan; 25(1):223-30. PubMed ID: 21109980
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.